Janux Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
JANX Key Statistics
Stock Snapshot
With a market cap of 1.24B, Janux Therapeutics(JANX) trades at $20.36. The stock has a price-to-earnings ratio of -12.31.
During the trading session on 2026-09-06, Janux Therapeutics(JANX) shares reached a daily high of $20.36 and a low of $19.57. At a current price of $20.36, the stock is +4.0% higher than the low and still 0.0% under the high.
Trading volume for Janux Therapeutics(JANX) stock has reached 700.49K, versus its average volume of 987.21K.
Over the past 52 weeks, Janux Therapeutics(JANX) stock has traded between a high of $35.34 and a low of $12.12.
Over the past 52 weeks, Janux Therapeutics(JANX) stock has traded between a high of $35.34 and a low of $12.12.
Analyst ratings
83%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.